Form 4: Alignment Healthcare Director Sells 25,000 Shares

Alignment Healthcare Director Joseph S. Konowiecki sold 25,000 shares of common stock at $19 per share under a Rule 10b5-1 plan.

Summary

• Joseph S. Konowiecki, a Director of Alignment Healthcare, Inc. (ALHC), disposed of 25,000 shares of common stock.
• The transaction occurred on November 25, 2025, at a price of $19 per share.
• Following this sale, Mr. Konowiecki directly beneficially owns 1,056,141 shares of Alignment Healthcare common stock.
• The transaction was made pursuant to a Rule 10b5-1 plan adopted on March 5, 2025.

Sentiment

Score: 5

Explanation: The filing reports a pre-planned insider sale, which is a neutral event in itself. However, insider selling can sometimes be perceived negatively by the market, even when planned, hence a neutral score with a slight leaning towards caution.

Negatives

• A director selling a significant number of shares (25,000) could be perceived negatively by investors, potentially signaling a lack of confidence, although it was a pre-planned sale.

Future Outlook

N/A. This filing reports a past insider transaction and does not contain forward-looking statements or guidance.

Industry Context

N/A. This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: May view the director's sale of shares as a potential signal, though the 10b5-1 plan indicates it was pre-scheduled and not necessarily based on new information.

Key Dates

Keywords

Alignment Healthcare, ALHC, Joseph S. Konowiecki, Insider Sale, Form 4, Director Transaction, Rule 10b5-1